NEW YORK (CBS.MW) -- While the overall biotech sector posted modest gains Tuesday, shares of DeCode Genetics surged after the company announced discoveries about genes linked to stroke and diabetes.
According to NASDAQ's s regulations, companies must keep their share prices over $1. DeCODE dipped below $1 on September 10, and has 180 days to bounce back to maintain a NASDAQ listing. (The ...